Javier Alegre‐Abarrategui

9.3k citations

27 papers · 3.9k indexed · 1 hit paper · h-index 18

Neurology top 0.2%
Cellular and Molecular Neuroscience top 1%
Physiology top 2%
Molecular Biology top 10%
Neurology top 1%

Co-authors: Richard Wade‐Martins Rosalind F. Roberts Israel Ampuero Justo Garcı́a de Yébenes Raquel Ros David G. Muñoz Janet Hoenicka Juan Carlos Gómez‐Esteban
Topics: Parkinson's Disease Mechanisms and Treatments (18 papers)Neurological disorders and treatments (9 papers)Alzheimer's disease research and treatments (6 papers)
Cited by: Neurology Cellular and Molecular Neuroscience
Journals: Nature Communications Brain Neurology
Partner nations: United Kingdom Canada Spain

In The Last Decade

Javier Alegre‐Abarrategui

25 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

2003 2.1k citations J.J. Zarranz, Javier Alegre‐Abarrategui et al. Annals of Neurology profile →

Peers

Countries citing papers authored by Javier Alegre‐Abarrategui

Since Specialization

Citations

This map shows the geographic impact of Javier Alegre‐Abarrategui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Alegre‐Abarrategui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Alegre‐Abarrategui more than expected).

Fields of papers citing papers by Javier Alegre‐Abarrategui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Alegre‐Abarrategui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Alegre‐Abarrategui. The network helps show where Javier Alegre‐Abarrategui may publish in the future.

Co-authorship network of co-authors of Javier Alegre‐Abarrategui

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Alegre‐Abarrategui. A scholar is included among the top collaborators of Javier Alegre‐Abarrategui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Alegre‐Abarrategui. Javier Alegre‐Abarrategui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Seeding-competent early tau multimers are associated with cell type-specific transcriptional signatures 2025 ·Acta Neuropathologica ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),S. Matthews,(unknown),(unknown),(unknown),Sarah J. Marzi,(unknown),Tara L. Spires‐Jones,Michael R. Johnson,Javier Alegre‐Abarrategui	1
2	Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity 2023 ·International Journal of Molecular Sciences ·(unknown),(unknown),(unknown),Javier Alegre‐Abarrategui	5
3	Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s disease 2021 ·Acta Neuropathologica Communications ·Nora Bengoa‐Vergniory,(unknown),(unknown),Connor Scott,Mariana Vargas‐Caballero,Magdalena Sastre,Richard Wade‐Martins,Javier Alegre‐Abarrategui	24
4	A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders 2020 ·Nature Communications ·Devika Agarwal,Cynthia Sandor,Viola Volpato,Tara M. Caffrey,Jimena Monzón‐Sandoval,Rory Bowden,Javier Alegre‐Abarrategui,Richard Wade‐Martins,Caleb Webber	187
5	Impairment of Macroautophagy in Dopamine Neurons Has Opposing Effects on Parkinsonian Pathology and Behavior 2019 ·Cell Reports ·Benjamin H.M. Hunn,Siv Vingill,Sarah Threlfell,Javier Alegre‐Abarrategui,(unknown),Thierry Deltheil,Nora Bengoa‐Vergniory,Peter L. Oliver,Milena Cioroch,Natalie M. Doig,David M. Bannerman,Stephanie J. Cragg,Richard Wade‐Martins	31
6	Selective vulnerability in α-synucleinopathies 2019 ·Acta Neuropathologica ·Javier Alegre‐Abarrategui,Katherine R. Brimblecombe,Rosalind F. Roberts,(unknown),Bension S. Tilley,Nora Bengoa‐Vergniory,Christos Proukakis	57
7	Alpha-Synuclein Proximity Ligation Assay (AS-PLA) in Brain Sections to Probe for Alpha-Synuclein Oligomers 2019 ·Methods in molecular biology ·Rosalind F. Roberts,Nora Bengoa‐Vergniory,Javier Alegre‐Abarrategui	11
8	Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction 2018 ·Neurobiology of Disease ·David F. Gordon,Ruxandra Dafinca,Jakub Scaber,Javier Alegre‐Abarrategui,Lucy Farrimond,Connor Scott,Daniel Biggs,(unknown),Peter L. Oliver,Benjamin Davies,Olaf Ansorge,Richard Wade‐Martins,Kevin Talbot	66
9	Alpha-synuclein oligomers: a new hope 2017 ·Acta Neuropathologica ·Nora Bengoa‐Vergniory,Rosalind F. Roberts,Richard Wade‐Martins,Javier Alegre‐Abarrategui	266
10	LRRK2BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function 2016 ·Human Molecular Genetics ·(unknown),Javier Alegre‐Abarrategui,Dawid Potgieter,Anna-Kristin Kaufmann,Richard Exley,Thierry Deltheil,Sarah Threlfell,Natalie Connor‐Robson,Katherine R. Brimblecombe,Rebecca L. Wallings,Milena Cioroch,David M. Bannerman,J. Paul Bolam,Peter J. Magill,Stephanie J. Cragg,Paul D. Dodson,Richard Wade‐Martins	56
11	Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain 2015 ·Brain ·Rosalind F. Roberts,Richard Wade‐Martins,Javier Alegre‐Abarrategui	201
12	Cytoplasmic Redistribution of Mutant TDP-43 in a BAC Based Mouse Model of Amyotrophic Lateral Sclerosis (P3.012) 2014 ·Neurology ·Kevin Talbot,David F. Gordon,Ruxandra Mutihac,Javier Alegre‐Abarrategui,Lucy Farrimond,Benjamin Davies,Richard Wade‐Martins	0
13	TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca2+ signaling in motor neurons 2014 ·Neurobiology of Disease ·Ruxandra Mutihac,Javier Alegre‐Abarrategui,David F. Gordon,Lucy Farrimond,(unknown),Kevin Talbot,Richard Wade‐Martins	44
14	RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum 2013 ·Brain ·Matthew L. Thomas,Javier Alegre‐Abarrategui,Richard Wade‐Martins	60
15	A GAA repeat expansion reporter model of Friedreich's ataxia recapitulates the genomic context and allows rapid screening of therapeutic compounds 2013 ·Human Molecular Genetics ·Michele MP Lufino,(unknown),Andrea H. Németh,Javier Alegre‐Abarrategui,Angela J. Russell,Richard Wade‐Martins	18
16	A novel method for autophagy detection in primary cells 2012 ·Autophagy ·Kanchan Phadwal,Javier Alegre‐Abarrategui,Alexander Watson,Luke Pike,Selvakumar Anbalagan,Ester M. Hammond,Richard Wade‐Martins,Andrew McMichael,Paul Klenerman,Anna Katharina Simon	118
17	LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model 2009 ·Human Molecular Genetics ·Javier Alegre‐Abarrategui,Helen Christian,Michele MP Lufino,Ruxandra Mutihac,(unknown),Olaf Ansorge,Richard Wade‐Martins	357
18	Parkinson disease, LRRK2 and the endocytic-autophagic pathway 2009 ·Autophagy ·Javier Alegre‐Abarrategui,Richard Wade‐Martins	44
19	LRRK2 is a component of granular alpha‐synuclein pathology in the brainstem of Parkinson's disease 2007 ·Neuropathology and Applied Neurobiology ·Javier Alegre‐Abarrategui,Olaf Ansorge,Margaret M. Esiri,Richard Wade‐Martins	61
20	The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiabreakdown → 2003 ·Annals of Neurology ·J.J. Zarranz,Javier Alegre‐Abarrategui,Juan Carlos Gómez‐Esteban,Elena Lezcano,Raquel Ros,Israel Ampuero,Lídice Vidal,Janet Hoenicka,Olga Rodriguez,Begoña Atarés,Verónica Llorens,(unknown),Teodoro del Ser,David G. Muñoz,Justo Garcı́a de Yébenes	2133

About Javier Alegre‐Abarrategui

Javier Alegre‐Abarrategui is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience, having authored 27 papers that have together received 3.9k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (9 papers) and Alzheimer's disease research and treatments (6 papers). The work is most often cited by research in Neurology (3.0k citations), Neurology (708 citations) and Cellular and Molecular Neuroscience (1.4k citations). Javier Alegre‐Abarrategui has collaborated with scholars based in United Kingdom, Canada and Spain. Frequent co-authors include Richard Wade‐Martins, Rosalind F. Roberts, Israel Ampuero, Justo Garcı́a de Yébenes, Raquel Ros, David G. Muñoz, Janet Hoenicka, Juan Carlos Gómez‐Esteban, Olga Rodriguez and Elena Lezcano. Their work appears in journals such as Nature Communications, Brain and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact